-
公开(公告)号:US20070112044A1
公开(公告)日:2007-05-17
申请号:US10575093
申请日:2004-10-08
申请人: Chikara Murakata , Nobuyoshi Amishiro , Yoji Ino , Junichiro Yamamoto , Toshiyuki Atsumi , Ryuichiro Nakai , Tomohisa Nakano
发明人: Chikara Murakata , Nobuyoshi Amishiro , Yoji Ino , Junichiro Yamamoto , Toshiyuki Atsumi , Ryuichiro Nakai , Tomohisa Nakano
IPC分类号: C07D285/12 , A61K31/433
CPC分类号: A61K31/433 , A61K31/4439 , A61K31/497 , C07D285/12
摘要: An antitumor agent comprising a thiadiazoline derivative represented by the general formula (I), or a pharmacologically acceptable salt thereof as an active ingredient: (wherein Z represents a sulfur atom and the like, R1 represents substituted or unsubstituted lower alkynyl and the like, R2 represents a hydrogen atom and the like, R3 represents substituted or unsubstituted lower alkyl and the like, and R4 represents substituted or unsubstituted aryl and the like), and the like are provided.
摘要翻译: 包含由通式(I)表示的噻二唑啉衍生物或其药理学上可接受的盐作为活性成分的抗肿瘤剂:其中Z表示硫原子等,R 1表示取代或 未取代的低级炔基等,R 2表示氢原子等,R 3表示取代或未取代的低级烷基等,R 4, / SUP>表示取代或未取代的芳基等)等。
-
公开(公告)号:US07745641B2
公开(公告)日:2010-06-29
申请号:US11918778
申请日:2006-04-19
申请人: Chikara Murakata , Nobuyoshi Amishiro , Toshiyuki Atsumi , Yoshinori Yamashita , Takeshi Takahashi , Ryuichiro Nakai , Hisashi Tagaya , Hiroko Takahashi , Jun Funahashi , Junichiro Yamamoto , Yuichi Fukuda
发明人: Chikara Murakata , Nobuyoshi Amishiro , Toshiyuki Atsumi , Yoshinori Yamashita , Takeshi Takahashi , Ryuichiro Nakai , Hisashi Tagaya , Hiroko Takahashi , Jun Funahashi , Junichiro Yamamoto , Yuichi Fukuda
IPC分类号: C07D207/00 , A61K31/40
CPC分类号: C07D209/46 , C07D209/48 , C07D401/14 , C07D403/04 , C07D403/14 , C07D405/04 , C07D405/14 , C07D409/04 , C07D409/14 , C07D471/04
摘要: The present invention provides a nitrogen-containing heterocyclic compound represented by formula (I): {wherein W represents a nitrogen atom or —CH—; X represents —C(═O)— or —CHR4— (wherein R4 represents a hydrogen atom, or the like}; R1 represents a group represented by the following formula: [wherein Q1 represents a nitrogen atom or —CR8— (wherein R8 represents a hydrogen atom, substituted or unsubstituted lower alkyl, or the like). Q2 represents —NR15— (wherein R15 represents a hydrogen atom, or the like) and R5 and R6 may be the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, or the like]; and R2 and R3 may be the same or different and each represents a hydrogen atom, halogen, substituted or unsubstituted lower alkyl, or the like} or a pharmaceutically acceptable salt thereof, and the like.
摘要翻译: 本发明提供由式(I)表示的含氮杂环化合物:其中W表示氮原子或-CH-; X表示-C(= O) - 或-CHR 4 - (其中R 4表示氢原子等); R 1表示由下式表示的基团:[其中Q1表示氮原子或-CR 8 - (其中R 8 表示氢原子,取代或未取代的低级烷基等),Q2表示-NR15-(式中,R15表示氢原子等),R5和R6可以相同或不同,表示氢原子, 取代或未取代的低级烷基等); R 2和R 3可以相同或不同,各自表示氢原子,卤素,取代或未取代的低级烷基等,或其药学上可接受的盐等 。
-
公开(公告)号:US20090054407A1
公开(公告)日:2009-02-26
申请号:US11918778
申请日:2006-04-19
申请人: Chikara Murakata , Nobuyoshi Amishiro , Toshiyuki Atsumi , Yoshinori Yamashita , Takeshi Takahashi , Ryuichiro Nakai , Hisashi Tagaya , Hiroko Takahashi , Jun Funahashi , Junichiro Yamamoto , Yuichi Fukuda
发明人: Chikara Murakata , Nobuyoshi Amishiro , Toshiyuki Atsumi , Yoshinori Yamashita , Takeshi Takahashi , Ryuichiro Nakai , Hisashi Tagaya , Hiroko Takahashi , Jun Funahashi , Junichiro Yamamoto , Yuichi Fukuda
IPC分类号: A61K31/55 , C07D209/04 , A61K31/404 , C07D403/14 , A61K31/496 , C07D401/14 , A61K31/541 , A61K31/506 , A61P35/00 , C07D417/14 , A61K31/454 , C07D413/14 , A61K31/5377 , A61K31/4439
CPC分类号: C07D209/46 , C07D209/48 , C07D401/14 , C07D403/04 , C07D403/14 , C07D405/04 , C07D405/14 , C07D409/04 , C07D409/14 , C07D471/04
摘要: The present invention provides a nitrogen-containing heterocyclic compound represented by formula (I): {wherein W represents a nitrogen atom or —CH—; X represents —C(═O)— or —CHR4— (wherein R4 represents a hydrogen atom, or the like); R1 represents a group represented by the following formula: [wherein Q1 represents a nitrogen atom or —CR8— (wherein R8 represents a hydrogen atom, substituted or unsubstituted lower alkyl, or the like). Q2 represents —NR15— (wherein R15 represents a hydrogen atom, or the like) and R5 and R6 may be the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, or the like]; and R2 and R3 may be the same or different and each represents a hydrogen atom, halogen, substituted or unsubstituted lower alkyl, or the like} or a pharmaceutically acceptable salt thereof, and the like.
摘要翻译: 本发明提供由式(I)表示的含氮杂环化合物:其中W表示氮原子或-CH-; X表示-C(-O) - 或-CHR 4 - (其中R 4表示氢原子等); R1表示由下式表示的基团:[其中Q1表示氮原子或-CR8-(其中R8表示氢原子,取代或未取代的低级烷基等)。 Q2表示-NR15-(其中R15表示氢原子等),R5和R6可以相同或不同,表示氢原子,取代或未取代的低级烷基等]。 R 2和R 3可以相同或不同,各自表示氢原子,卤素,取代或未取代的低级烷基等}或其药学上可接受的盐等。
-
公开(公告)号:US20070276017A1
公开(公告)日:2007-11-29
申请号:US10560230
申请日:2004-06-09
申请人: Chikara Murakata , Yoji Ino , Kazuhiko Kato , Junichiro Yamamoto , Yushi Kitamura , Ryuichiro Nakai , Tomohisa Nakano , Tetsuya Tsujita
发明人: Chikara Murakata , Yoji Ino , Kazuhiko Kato , Junichiro Yamamoto , Yushi Kitamura , Ryuichiro Nakai , Tomohisa Nakano , Tetsuya Tsujita
IPC分类号: A61K31/454 , C07D285/12 , A61K31/433 , C07D417/02
CPC分类号: C07D285/135
摘要: A thiadiazoline derivative represented by the general formula (I), or a pharmacologically acceptable salt thereof: [wherein R1 represents a hydrogen atom and the like, R2 represents a hydrogen atom, —COR5 (wherein R5 represents lower alkyl and the like) and the like, R3 represents lower alkyl and the like, R4 represents aryl and the like, A represents —(CH2)n— (wherein n represents an integer of 1 to 6) and the like, and B represents —NR6R7 (wherein R6 and R7 are the same or different and represent a hydrogen atom, lower alkyl and the like) and the like] is provided.
摘要翻译: 由通式(I)表示的噻二唑啉衍生物或其药理学上可接受的盐:[其中R 1表示氢原子等,R 2表示氢 原子,-COR 5(其中R 5表示低级烷基等)等,R 3表示低级烷基等, R 4表示芳基等,A表示 - (CH 2 CH 2)n - (其中n表示1至6的整数)和 和B代表-NR 6 R 7(其中R 6和R 7和R 7相同或不同) 不同,表示氢原子,低级烷基等)等。
-
公开(公告)号:US20080194653A1
公开(公告)日:2008-08-14
申请号:US11909289
申请日:2006-03-22
申请人: Chikara Murakata , Kazuhiko Kato , Junichiro Yamamoto , Ryuichiro Nakai , Seiho Okamoto , Yoji Ino , Yushi Kitamura , Toshikazu Saitoh , Takeshi Katsuhira
发明人: Chikara Murakata , Kazuhiko Kato , Junichiro Yamamoto , Ryuichiro Nakai , Seiho Okamoto , Yoji Ino , Yushi Kitamura , Toshikazu Saitoh , Takeshi Katsuhira
IPC分类号: A61K31/433 , C07D285/08 , A61P35/00
CPC分类号: A61K31/433 , A61K31/454 , C07D285/135 , C07D417/04
摘要: A therapeutic and/or prophylactic agent for a solid tumor, which comprises a thiadiazoline derivative represented by the general formula (I), or a pharmaceutically acceptable salt thereof: [wherein, n represents an integer of 1 to 3, R1 represents a hydrogen atom, R2 represents lower alkyl, or R1 and R2 are combined together to represent alkylene, R3 represents lower alkyl, R4 represents NHSO2R6 (wherein R6 represents hydroxy or the like) or the like, and R5 represents aryl or the like] and the like are provided.
摘要翻译: 含有通式(I)表示的噻二唑啉衍生物或其药学上可接受的盐的固体肿瘤治疗剂和/或预防剂,其中n表示1〜3的整数,R 1 R 2表示氢原子,R 2表示低级烷基,或R 1和R 2结合在一起代表亚烷基,R 低级烷基表示低级烷基,R 4表示NHSO 2 R 6(其中R 6或以上) >表示羟基等)等,R 5表示芳基等]等。
-
公开(公告)号:USD671235S1
公开(公告)日:2012-11-20
申请号:US29415185
申请日:2012-03-08
申请人: Junichiro Yamamoto , Shigeru Motoki
设计人: Junichiro Yamamoto , Shigeru Motoki
-
公开(公告)号:US20120223519A1
公开(公告)日:2012-09-06
申请号:US13508760
申请日:2010-11-12
申请人: Junichiro Yamamoto
发明人: Junichiro Yamamoto
IPC分类号: F16L43/02
CPC分类号: F16L23/02 , F16L21/00 , F16L23/162 , F16L23/18 , F16L37/008 , F16L41/086
摘要: An object of the invention is to provide a pipe joining structure which allows the parts cost to be reduced while requiring a reduced number of seal portions. In order to accomplish the object, the invention provides a pipe joining structure 10 for joining a pipe 12 disposed to extend along an equipment housing 11 to a fluid passage 11a of the equipment housing 11 by bending an end portion 12a of the pipe 12 about 90 degrees to form a bend portion and fitting a tip of the bend portion into an opening of the fluid passage 11a, characterized in that: a stay 13 is fitted over the bend portion 12a of the pipe; a tip of the pipe is formed with a flange 12b; an O-ring 14 is fitted between the stay and the flange of the pipe; and the stay is fixed to the equipment housing, to thereby join the tip of the pipe to the equipment housing.
摘要翻译: 本发明的目的是提供一种能够减少零件成本并减少密封部分数量的管接合结构。 为了实现该目的,本发明提供了一种管接合结构10,用于将设置成沿着设备壳体11延伸的管12连接到设备壳体11的流体通道11a,通过将管12的端部12a弯曲约90° 以形成弯曲部分并将弯曲部分的尖端装配到流体通道11a的开口中,其特征在于:支柱13装配在管道的弯曲部分12a上; 管的尖端形成有凸缘12b; O形环14安装在支柱和管的凸缘之间; 并且将支架固定到设备壳体,从而将管道的尖端接合到设备壳体。
-
公开(公告)号:USD662621S1
公开(公告)日:2012-06-26
申请号:US29398712
申请日:2011-08-03
-
公开(公告)号:USD648060S1
公开(公告)日:2011-11-01
申请号:US29386112
申请日:2011-02-24
-
公开(公告)号:USD636922S1
公开(公告)日:2011-04-26
申请号:US29356387
申请日:2010-02-25
-
-
-
-
-
-
-
-
-